Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for TrueBlue (TBI) over the last 17 years, with Q3 2025 value amounting to $3.6 million.

  • TrueBlue's Capital Expenditures fell 3537.09% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.8 million, marking a year-over-year decrease of 3410.09%. This contributed to the annual value of $24.2 million for FY2024, which is 2278.1% down from last year.
  • According to the latest figures from Q3 2025, TrueBlue's Capital Expenditures is $3.6 million, which was down 3537.09% from $4.3 million recorded in Q2 2025.
  • Over the past 5 years, TrueBlue's Capital Expenditures peaked at $10.0 million during Q1 2021, and registered a low of $3.6 million during Q3 2025.
  • Moreover, its 5-year median value for Capital Expenditures was $7.4 million (2024), whereas its average is $7.0 million.
  • Data for TrueBlue's Capital Expenditures shows a peak YoY increase of 11385.22% (in 2021) and a maximum YoY decrease of 4239.51% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows TrueBlue's Capital Expenditures stood at $6.2 million in 2021, then grew by 27.38% to $7.9 million in 2022, then rose by 3.02% to $8.2 million in 2023, then crashed by 35.5% to $5.3 million in 2024, then crashed by 31.48% to $3.6 million in 2025.
  • Its Capital Expenditures stands at $3.6 million for Q3 2025, versus $4.3 million for Q2 2025 and $4.7 million for Q1 2025.